Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
Nicholas D. James(Royal Marsden NHS Foundation Trust), Matthew R. Sydes(MRC Clinical Trials Unit at UCL), Emma Gray(Wellcome Sanger Institute), John M. Russell, Carys Thomas(Cancer Research UK), Silke Gillessen(Institute of Oncology Research), Jo Bowen(Cancer Research UK), Mahesh Parmar(University College London), Angus Robinson(Royal Sussex County Hospital), John Wagstaff(Maastricht University Medical Centre), Anjali Zarkar(Cancer Research UK), Peter Hoskin(University of Manchester), Narayanan Srihari(Shrewsbury and Telford Hospital NHS Trust), David P. Dearnaley(Royal Marsden NHS Foundation Trust), Malcolm D. Mason(Royal Marsden Hospital), William Cross(Leeds Teaching Hospitals NHS Trust), Claire Amos(MRC Clinical Trials Unit at UCL), Mohan Hingorani(Hull and East Yorkshire Hospitals NHS Trust), Clare Gilson(Cancer Research UK), Robert J. Jones(Beatson West of Scotland Cancer Centre), Joe M. O’Sullivan(San Antonio College), Julian Money‐Kyrle(Royal Surrey County Hospital), San Aung(Royal Devon & Exeter NHS Foundation Trust), Joanna Gale(Queen Alexandra Hospital), Andrew Protheroe(University of Oxford), Omi Parikh(Royal Blackburn Teaching Hospital), Noel W. Clarke(The Christie NHS Foundation Trust), David Matheson(MRC Clinical Trials Unit at UCL), Johann S. de Bono(Royal Marsden NHS Foundation Trust), J.F. Lester(Cancer Research UK), F. Adab(University Hospitals of North Midlands NHS Trust), Alison Birtle(University of Lancashire), Dominik Berthold(University Hospital of Lausanne), Susannah Brock, Chris Brawley(Cancer Research UK), Catherine Ferguson(Cancer Research UK), James Wylie(Cancer Research UK), Zafar Malik(Cancer Research UK), Christopher Parker(Royal Marsden NHS Foundation Trust), Melissa Spears(MRC Clinical Trials Unit at UCL), Simon Chowdhury(Sarah Cannon Research Institute), Fiona McKinna, A.W.S. Ritchie(MRC Clinical Trials Unit at UCL), Prabir Chakraborti(Royal Derby Hospital), Gerhardt Attard(London Cancer), Robin Millman(MRC Clinical Trials Unit at UCL), Neil McPhail(Cancer Research UK)
Cited by 1,795
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
|New England Journal of Medicine|2013|3.3k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k